Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that its recently published findings from its "Targeted Intra-tumoral Hyperthermia with Uniquely ...

Total revenue of $6.3M Includes $3.3 Million of Product Revenue in Addition to a One-Time Upfront Payment of $3.0 Million in License Revenue from ...

All treated AML patients in both the original and expansion cohorts through January 17, 2025 remain in complete remission. The original cohort of AML patients has reached a median CR of 23.3 months, ...

Robin Fields ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as ...

CEO George Colony emphasized the completion of Forrester's multi-year transition to the Forrester Decisions (FD) platform, with 80% of contract value (CV) now on the FD portfolio. He noted that the ...

Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and fiscal year of 2024, provided an update on progress toward achieving key ...

Research reports from Morningstar & Argus help you make better investment decisions. Leverage these to understand future stock performance and identify high performing investment ideas. You can ...

The firm plans to use the proceeds to support commercial expansion in the US and EU, and for research, potential regulatory submissions, and general corporate purposes.

The lessons of the Holocaust are more relevant now than ever. Your contribution will have an immediate and direct impact on educating future generations. Make a donation, give a tribute gift, ...